Ruiqing Ma

4PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 26, 2026
Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation-Nutrition Marker in Appendiceal High-Grade Pseudomyxoma Peritonei: A 10-Year Single-Center Study.

|Jan 14, 2025
Prophylactic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous tumors with early and limited disease after completely removed.

Chong Wang, Yun Jia, Guanjun Shi

|Sep 28, 2023
Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.

Yu-Lin Lin, Jun-Qi Zhu, Rui-Qing Ma

|Sep 22, 2022
Preoperative systemic chemotherapy does not benefit for appendiceal pseudomyxoma peritonei.

Ruiqing Ma, Dongmei Lu, Shilin Xue

Pageof 1

Frequent Collaborators

1 joint publications

Yu-Lin Lin

1 joint publications

Jun-Qi Zhu

1 joint publications

Wei Meng

1 joint publications

Zi-Yue Wang